Top

Published in:

Open Access 01-10-2018 | Original Paper

Intimate Partner Violence and HIV Sexual Risk Behaviour Among Women Who Inject Drugs in Indonesia: A Respondent-Driven Sampling Study

Authors: Claudia Stoicescu, Lucie D. Cluver, Thees Spreckelsen, Marisa Casale, Anindita Gabriella Sudewo, Irwanto

Published in: AIDS and Behavior | Issue 10/2018

Abstract

Women who inject drugs are disproportionately affected by HIV and intimate partner violence (IPV); however, the link between IPV and HIV remains under-researched among substance-using women in low- and middle-income countries. This study examined associations and additive effects of different forms of IPV victimization (psychological, physical and/or injurious, and sexual) on HIV sexual risk behavior among women who inject drugs in Indonesia. Respondent-driven sampling (RDS) was used to recruit 731 women from Greater Jakarta and Bandung, West Java. RDS-II weighted prevalence of any past-year IPV was 68.9% (95% CI 65.0, 72.6) in Jakarta and 55.9% (95% CI 48.0, 63.5) in Bandung. In separate logistic regressions controlling for socio-demographic covariates, all three forms of IPV showed statistically significant associations with sexual risk behavior. After adjusting for all IPV types, psychological (OR 1.87; 95% CI 1.17, 2.99; p = 0.009) and sexual (OR 1.98; 95% CI 1.22, 3.21; p = 0.006) IPV independently predicted women’s sexual risk behavior. Marginal effects models suggested that co-occurrence of multiple forms of IPV had greater adverse consequences: sexual risk behavior was reported by 64.1% of women who did not experience any IPV, but increased to 89.9% among women exposed to all three types. Comprehensive harm reduction services that integrate IPV monitoring and prevention are urgently needed to reduce both HIV and IPV.

Available only for authorised users

Larney S, Mathers BM, Poteat T, Kamarulzaman A, Degenhardt L. Global epidemiology of HIV among women and girls who use or inject drugs: current knowledge and limitations of existing data. J Acquir Immune Defic Syndr. 2015;69(2):S100–9.CrossRefPubMedPubMedCentral

Des Jarlais DC, Feelemyer JP, Modi SN, Arasteh K, Hagan H. Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. Drug Alcohol Depend. 2012;124(1–2):95–107.CrossRefPubMedPubMedCentral

Strathdee SA, Hallett TB, Bobrova N, Thodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376:268–84.CrossRefPubMed

Auerbach JD, Smith LR. Theoretical foundations of research focused on HIV prevention among substance-involved women: a review of observational and intervention studies. J Acquir Immune Defic Syndr. 2015;69(2):S146–54.CrossRefPubMedPubMedCentral

Gilbert L, Raj A, Hien D, Stockman J, Terlikbayeva A, Wyatt G. Targeting the SAVA (substance abuse, violence, and AIDS) syndemic among women and girls: a global review of epidemiology and integrated interventions. J Acquir Immune Defic Syndr. 2015;69(2):S118–27.CrossRefPubMedPubMedCentral

El-Bassel N, Gilbert L, Witte S, Wu E, Chang M. Intimate partner violence and HIV among drug-involved women: contexts linking these two epidemics—challenges and implications for prevention and treatment. Subst Use Misuse. 2011;46(2–3):295–306.CrossRefPubMed

Moore TM, Stuart GL, Meehan JC, Rhatigan DL, Hellmuth JC, Keen SM. Drug abuse and aggression between intimate partners: a meta-analytic review. Clin Psychol Rev. 2008;28(2):247–74.CrossRefPubMed

Wu E, El-Bassel N, Witte SS, Gilbert L, Chang M. Intimate partner violence and HIV risk among urban minority women in primary health care settings. AIDS Behav. 2003;7(3):291–301.CrossRefPubMed

Campbell JC, Lucea MB, Stockman JK, Draughon JE. Forced sex and HIV risk in violent relationships. Am J Reprod Immunol. 2013;69:41–4.CrossRefPubMed

10.

Maman S, Campbell S, Sweat MD, Gielen AC. The intersections of HIV and violence: directions for future research and interventions. Soc Sci Med. 2000;50(4):459–78.CrossRefPubMed

11.

Kouyoumdjian FG, Calzavara LM, Bondy SJ, O’Campo P, Serwadda D, Nalugoda F, et al. Intimate partner violence is associated with incident HIV infection in women in Uganda. AIDS. 2013;27(8):1331–8.CrossRefPubMed

12.

Follingstad DR. The impact of psychological aggression on women’s mental health and behaviour: the status of the field. Trauma Violence Abuse. 2009;10(3):271–89.CrossRefPubMed

13.

WHO. WHO multi-country study on women’s health and domestic violence against women report: initial results on prevalence, health outcomes and women’s responses. Geneva: World Health Organization; 2005.

14.

Dunkle KL, Decker MR. Gender-based violence and HIV: reviewing the evidence for links and causal pathways in the general population and high-risk groups. Am J Reprod Immunol. 2013;69(Suppl 1):20–6.CrossRefPubMed

15.

Meyer JP, Springer SA, Altice FL. Substance abuse, violence, and HIV in women: a literature review of the syndemic. J Women’s Health. 2011;20(7):991–1006.CrossRef

16.

Li Y, Marshall CM, Rees HC, Nunez A, Ezeanolue EE, Ehiri JE. Intimate partner violence and HIV infection among women: a systematic review and meta-analysis. J Int AIDS Soc. 2014;17:18845.CrossRefPubMedPubMedCentral

17.

UNAIDS. HIV in Asia and the Pacific. Bangkok, Thailand: Joint United Nations Programme on HIV/AIDS. Geneva: UNAIDS; 2013.

18.

Indonesian National AIDS Commission. Republic of Indonesia country report on the follow up to the declaration of commitment on HIV/AIDS (UNGASS): reporting period 2010–2011. Jakarta: Indonesian National AIDS Commission; 2012.

19.

Habsari R, Rahardjo T, Rahmah A, Handoyo P. Perempuan-perempuan di langkar Napza: Laporan kajian kebutuhan pengguna Napza suntik perempuan di delapan kota di Indonesia, 2007. Jakarta: National AIDS Commission; 2007.

20.

Sari SW, Nurmaya BV. Pengalaman perempuan pengguna narkotika suntik (Penasun) dalam mengakses layanan harm reduction: sebuah kajian cepat. Jakarta: Indonesia Yayasan Stigma; 2009.

21.

Spooner C, Saktiawati AMI, Lazuardi E, Worth H, Subronto YW, Padmawati RS. Women who inject drugs in central Java and HIV risk. Sydney: International HIV Research Group, University of New South Wales; 2010.

22.

Indonesian National AIDS Commission. Republic of Indonesia country report on the follow up to the declaration of commitment on HIV/AIDS (UNGASS): reporting period 2008–2009. Jakarta: Indonesian National AIDS Commission; 2009.

23.

Saktiawati AMI, Worth H, Lazuardi E, Spooner C, Subronto YW, Padmawati RS. ‘I just trust him’: the notion of consideration as a barrier to condom use amongst women who inject drugs in Central Java. World J AIDS. 2013;03(04):298–304.CrossRef

24.

Stigma Foundation. Indonesia female drug user baseline survey 2010. Jakarta: Stigma Foundation; 2010.

25.

Lazuardi E, Worth H, Saktiawati AM, Spooner C, Padmawati R, Subronto Y. Boyfriends and injecting: the role of intimate male partners in the life of women who inject drugs in Central Java. Cult Health Sex. 2012;14(5):491–503.CrossRefPubMed

26.

Ministry of Health. Size estimate workbooks. Jakarta: Indonesia Ministry of Health; 2012.

27.

Johnston LG. Behavioural surveillance: Introduction to respondent driven sampling (training manual). Georgia: United Stated Centers for Disease Control and Prevention; 2008.

28.

Salganik MJ. Variance estimation, design effects, and sample size calculations for respondent-driven sampling. J Urban Health. 2006;83(6 Suppl):i98–112.CrossRefPubMed

29.

Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005;2:S67–72.CrossRef

30.

Heckathorn D. Respondent-driven sampling II: deriving valid populations estimates from chain-referral samples of hidden populations. Soc Probl. 2002;49(1):11–34.CrossRef

31.

White RG, Hakim AJ, Salganik MJ, Spiller MW, Johnston LG, Kerr L, et al. Strengthening the reporting of observational studies in epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement. J Clin Epidemiol. 2015;68(12):1463–71.CrossRefPubMedPubMedCentral

32.

Ministry of Health. Integrated behavioural and biological survey. Jakarta: Ministry of Health; 2011.

33.

WHO, UNODC, UNAIDS. WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Geneva: World Health Organization; 2012.

34.

World Health Organization. Management of subtance abuse: process of translation and adaptation of instruments. 2017. http://www.who.int/substance_abuse/research_tools/translation/en/.

35.

Hartung C, Lerer A, Anokwa Y, Tseng C, Brunette W, Borriello G. Open Data Kit: Tools to build information services for developing regions. In: 4th ACM/IEEE International Conference on Information and Communication Technologies and Development; December 13–15, 2010; London, United Kingdom. 2010.

36.

Fry C, Hall WD, Ritter A, Jenkinson R. The ethics of paying drug users who participate in research: a review and practical recommendations. J Empir Res Hum Res Ethics. 2006;1(4):21–36.CrossRefPubMed

37.

Festinger DS, Dugosh KL. Paying substance abusers in research studies: where does the money go? Am J Drug Alcohol Abuse. 2012;38(1):43–8.CrossRefPubMed

38.

Alliance for Public Health. Automated records management system in harm reduction programs: SyrEx2. User’s manual. Kiev: Alliance for Public Health; 2011.

39.

UNAIDS. Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 united nations political declaration on HIV and AIDS. Geneva: Joint United Nations Programme on HIV/AIDS; 2014.

40.

WHO. Guidelines for the management of sexually transmitted infections. Geneva: World Health Organization; 2003.

41.

El-Bassel N, Gilbert L, Wu E, Chang M, Gomes C, Vinocur D, et al. Intimate partner violence prevalence and HIV risks among women receiving care in emergency departments: implications for IPV and HIV screening. Emerg Med J. 2007;24(4):255–9.CrossRefPubMedPubMedCentral

42.

Vuylsteke B. Current status of syndromic management of sexually transmitted infections in developing countries. Sex Transm Infect. 2004;80(5):333–4.CrossRefPubMedPubMedCentral

43.

Strauss MA, Boney-McCoy S, Sugarman DB. The revised conflict tactics scales (CTS2): development and preliminary psychometric data. J Fam Issues. 1996;17(3):283–316.CrossRef

44.

Strauss MA, Douglas EM. A short form of the revised conflict tactics scales, and typologies for severity and mutuality. Violence Vict. 2004;19(5):507–20.CrossRef

45.

Strauss MA. Cross-cultural reliability and validity of the revised conflict tactics scales: a study of university student dating couples in 17 nations. Cross-Cult Res. 2004;38(4):407–32.CrossRef

46.

Gilbert L, El-Bassel N, Schilling R, Wada T, Bennet B. Partner violence and sexual HIV risk behaviors among women in methadone treatment. AIDS Behav. 2000;4(3):261–9.CrossRef

47.

Cavanaugh CE, Hansen NB, Sullivan TP. HIV sexual risk behavior among low-income women experiencing intimate partner violence: the role of posttraumatic stress disorder. AIDS Behav. 2010;14(2):318–27.CrossRefPubMedPubMedCentral

48.

Panchanadeswaran S, Frye V, Nandi V, Galea S, Vlahov D, Ompad D. Intimate partner violence and consistent condom use among drug-using heterosexual women in New York City. Women Health. 2010;50(2):107–24.CrossRefPubMedPubMedCentral

49.

Stoicescu C, Sari SW, Esteria-Tobing N. Risk and protective factors for HIV transmission among women who inject drugs in Jakarta, Indonesia: An exploratory study. In: 10th International Congress on AIDS in Asia and the Pacific (ICAAP); Busan, South Korea. 2011.

50.

Statistics Indonesia. Census Indonesia: Social and population data. Jakarta, Indonesia. 2013.

51.

El-Bassel N, Gilbert L, Wu E, Go H, Hill J. Relationship between drug abuse and intimate partner violence: a longitudinal study among women receiving methadone. Am J Public Health. 2005;95(3):465–70.CrossRefPubMedPubMedCentral

52.

Illangasekare S, Burke J, Chander G, Gielen A. The syndemic effects of intimate partner violence, HIV/AIDS, and substance abuse on depression among low-income urban women. J Urban Health. 2013;90(5):934–47.CrossRefPubMedPubMedCentral

53.

Loeliger KB, Marcus R, Wickersham JA, Pillai V, Kamarulzaman A, Altice FL. The syndemic of HIV, HIV-related risk and multiple co-morbidities among women who use drugs in Malaysia: important targets for intervention. Addict Behav. 2016;53:31–9.CrossRefPubMed

54.

Klee H. HIV risks for women drug injectors: heroin and amphetamine users compared. Addiction. 1993;88:1055–62.CrossRefPubMed

55.

Lorvick J, Martinez A, Gee L, Kral AH. Sexual and injection risk among women who inject methamphetamine in San Francisco. J Urban Health. 2006;83(3):497–505.CrossRefPubMedPubMedCentral

56.

Oldenburg CE, Perez-Brumer AG, Reisner SL. Poverty matters: contextualizing the syndemic condition of psychological factors and newly diagnosed HIV infection in the United States. AIDS. 2014;28(18):2763–9.CrossRefPubMedPubMedCentral

57.

Aidala A, Cross JE, Stall R, Harre D, Sumartojo E. Housing status and HIV risk behaviors: implications for prevention and policy. AIDS Behav. 2005;9(3):251–65.CrossRefPubMed

58.

Schonlau M, Liebau E. Respondent driven sampling. Stata J. 2012;12(1):72–93.

59.

Schonlau M, Liebau E. Software updates: st0247. Stata J. 2013;13(4):884.

60.

Goel S, Salganik MJ. Assessing respondent-driven sampling. Proc Natl Acad Sci USA. 2010;107(15):6743–7.CrossRefPubMed

61.

Hosmer DW, Lemenshow S. Applied logistic regression. New York: Wiley; 1989.

62.

Katz M. Multivariable analysis. Cambridge: Cambridge University Press; 2011.CrossRef

63.

Berry WD, Feldman S. Multiple regression in practice (quantitative applications in the social sciences). Thousand Oaks: SAGE Publications; 1985.CrossRef

64.

Heckathorn D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–99.CrossRef

65.

Volz E, Heckathorn D. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24(1):79–97.

66.

Gile KJ, Johnston LG, Salganik MJ. Diagnostics for respondent-driven sampling. J R Stat Soc. 2015;178(1):241–69.CrossRef

67.

Statistics Indonesia. Prevalence of violence against women in Indonesia: results from the 2016 Women’s Life Experience Survey. Jakarta, Indonesia. 2017.

68.

Rottingen JA, Cameron W, Garnett G. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much is really known? Sex Transm Dis. 2001;28(10):579–97.CrossRefPubMed

69.

Chesson HW, Pinkerton SD. Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions. J Acquir Immune Defic Syndr. 2000;24(1):48–56.CrossRefPubMed

70.

Gielen AC, Ghandour RM, Burke JG, Mahoney P, McDonnell KA, O’Campo P. HIV/AIDS and intimate partner violence: intersecting women’s health issues in the United States. Trauma Violence Abuse. 2007;8(2):178–98.CrossRefPubMed

71.

Hayati EN, Hogberg U, Hakimi M, Ellsberg MC, Emmelin M. Behind the silence of harmony: risk factors for physical and sexual violence among women in rural Indonesia. BMC Women’s Health. 2011;11(52):1–8.

72.

Roberts A, Mathers B, Degenhardt L. Women who inject drugs: a review of their risks, experiences and needs. Sydney: National Drug and Alcohol Research Centre (NDARC), University of New South Wales; 2010.

73.

Kilpatrick DG, Acierno R, Resnick HS, Saunders BE, Best CL. A 2-year longitudinal analysis of the relationship between violent assault and substance use in women. J Consult Clin Psychol. 1997;65:834–7.CrossRefPubMed

74.

El-Bassel N, Shaw SA, Dasgupta A, Strathdee SA. Drug use as a driver of HIV risks: re-emerging and emerging issues. Curr Opin HIV/AIDS. 2014;9(2):150–5.CrossRef

75.

Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller J, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med. 2008;66(4):911–21.CrossRefPubMed

76.

Ullman SE, Relyea M, Peter-Hagene L, Vasquez AL. Trauma histories, substance use coping, PTSD, and problem substance use among sexual assault victims. Addict Behav. 2013;38(6):2219–23.CrossRefPubMedPubMedCentral

77.

Miller M. A model to explain the relationship between sexual abuse and HIV risk among women. AIDS Care. 1999;11(1):3–20.CrossRefPubMed

78.

Plotzker RE, Metzger DS, Holmes WC. Childhood sexual and physical abuse histories, PTSD, depression, and HIV risk outcomes in women injection drug users: a potential mediating pathway. Am J Addict. 2007;16(6):431–8.CrossRefPubMed

79.

Devries KM, Mak JY, Bacchus LJ, Child JC, Falder G, Petzold M, et al. Intimate partner violence and incident depressive symptoms and suicide attempts: a systematic review of longitudinal studies. PLoS Med. 2013;10(5):e1001439.CrossRefPubMedPubMedCentral

80.

Shannon K, Strathdee S, Shoveller J, Zhang R, Montaner J, Tyndall M. Crystal methamphetamine use among female street-based sex workers: moving beyond individual-focused interventions. Drug Alcohol Depend. 2011;113(1):76–81.CrossRefPubMedPubMedCentral

81.

Neverndorff L, Praptoraharjo I. Crystal-meth use and HIV-related risk behaviors in Indonesia. Jakarta: Mainline; 2015.

82.

UNODC. World drug report. Vienna: United Nations Office on Drugs ans Crime; 2016. p. 2016.

83.

Abel-Ollo K, Rahu M, Rajaleid K, Talu A, Ruutel K, Platt L, et al. Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia. AIDS Care. 2009;21(7):851–7.CrossRefPubMed

84.

Noor SWB, Ross MW, Lai D, Risser JM. Drug and sexual HIV risk behaviours related to knowledge of HIV serostatus among injection drug users in Houston, Texas. Int J STD AIDS. 2014;25(2):89–95.CrossRefPubMed

85.

Pellowski JA, Kalichman SC, Matthews KA, Adler N. A pandemic of the poor: social disadvantage and the U.S. HIV epidemic. Am J Psychol. 2013;68(4):197–209.CrossRef

86.

Wagner KD, Hudson SM, Latka MH, Strathdee SA, Thiede H, Mackesy-Amiti ME, et al. The effect of intimate partner violence on receptive syringe sharing among young female injection drug users: an analysis of mediation effects. AIDS Behav. 2009;13(2):217–24.CrossRefPubMed

87.

Sherman SG, Latkin CA, Gielen AC. Social factors related to syringe sharing among injecting partners: a focus on gender. Subst Use Misuse. 2009;36(14):2113–36.CrossRef

88.

Latkin C, Vlahov D. Socially desirable response tendency as a correlate of accuracy of self- reported HIV serostatus for HIV-positive drug users. Addiction. 1998;93(8):1191–7.CrossRefPubMed

89.

Broadhead RS, Heckathorn D, Weakliem DL, Anthony DL, Madray H, Mills RJ, et al. Harnessing peer networking as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998;113(1):42–57.PubMedPubMedCentral

90.

Goodson L, Phillimore J. Recruitment and capacity-building challenges in participatory research involving young people in Northern Ireland. In: MacCartan C, Burns S, Schubotz D, editors. Community research for participation: from theory to method. Bristol: Policy Press; 2012. p. 283.

91.

Tyldum G, Johnston LG, editors. Applying respondent driven sampling to migrant populations: lessons from the field. London: Palgrave Macmillan; 2014.

Title: Intimate Partner Violence and HIV Sexual Risk Behaviour Among Women Who Inject Drugs in Indonesia: A Respondent-Driven Sampling Study
Authors: Claudia Stoicescu
Lucie D. Cluver
Thees Spreckelsen
Marisa Casale
Anindita Gabriella Sudewo
Irwanto
Publication date: 01-10-2018
Publisher: Springer US
Published in: AIDS and Behavior / Issue 10/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-018-2186-2

ACC 2024 Congress Coverage

Heart Failure Video

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Intimate Partner Violence and HIV Sexual Risk Behaviour Among Women Who Inject Drugs in Indonesia: A Respondent-Driven Sampling Study

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2018

Patient–Provider Communication Barriers and Facilitators to HIV and STI Preventive Services for Adolescent MSM

Addressing Stigma Through a Virtual Community for People Living with HIV: A Mixed Methods Study of the PositiveLinks Mobile Health Intervention

Patterns of Gender-Based Violence and Associations with Mental Health and HIV Risk Behavior Among Female Sex Workers in Mombasa, Kenya: A Latent Class Analysis

Preferences for Sexual Health Smartphone App Features Among Gay and Bisexual Men

The Impact of Cell Phone Support on Psychosocial Outcomes for Youth Living with HIV Nonadherent to Antiretroviral Therapy

Social Support and Violence-prone Relationships as Predictors of Disclosure of HIV Status Among Newly Diagnosed HIV-positive South Africans

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page